Evaluation of the clinical usefulness of rupatadine in patients with seasonal allergic rhinitis.
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2018
Price : $35 *
At a glance
- Drugs Rupatadine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 02 Apr 2018 Status changed from active, no longer recruiting to completed.
- 15 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Mar 2018 Status changed from not yet recruiting to recruiting.